(VIANEWS) – Equus Total Return (EQS), Eagle Point Credit Company (ECC), Bank7 Corp. (BSVN) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Equus Total Return (EQS)
139.2% sales growth and 26.15% return on equity
Equus Total Return, Inc. is a business development company (BDC) specializing in leveraged buyouts, management buyouts, corporate partnerships/joint ventures, growth and expansion capital, acquisition financing, roll-up acquisition strategies, operational turnarounds, recapitalizations of existing businesses, special situations, equity and equity-oriented securities issued by privately owned companies, debt securities including subordinate debt, debt convertible into common or preferred stock, or debt combined with warrants and common and preferred stock, and preferred equity financing. It invests in small to mid-sized companies and acts as a lead investor. It invests in technology, telecommunication, financial services, natural resource and industrial manufacturing and services. It invests in companies engaged in the alternative energy, real estate, healthcare, education, e-learning, leisure and entertainment, and foreign investment sector in the United States, China, India, and Europe. It investments include common and preferred stock, debt convertible into common or preferred stock, debt combined with warrants and options, and other rights to acquire common or preferred stock. It seeks to invest in companies between $1 million to $25 million with revenues between $5 million and $150 million with EBITDA between $2 million to $50 million. It seeks to take control and non-control equity positions. Equus Total Return, Inc. was founded in 1991 and is based in Houston, Texas with additional office in Vancouver, Canada.
Earnings Per Share
As for profitability, Equus Total Return has a trailing twelve months EPS of $0.81.
PE Ratio
Equus Total Return has a trailing twelve months price to earnings ratio of 1.8. Meaning, the purchaser of the share is investing $1.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.15%.
Volume
Today’s last reported volume for Equus Total Return is 7461 which is 53.51% below its average volume of 16050.
2. Eagle Point Credit Company (ECC)
26.6% sales growth and 18.54% return on equity
Eagle Point Credit Company Inc. is a closed ended fund launched and managed by Eagle Point Credit Management LLC. It invests in fixed income markets of the United States. The fund invests equity and junior debt tranches of collateralized loan obligations consisting primarily of below investment grade U.S. senior secured loans. Eagle Point Credit Company Inc. was formed on March 24, 2014 and is domiciled in the United States.
Earnings Per Share
As for profitability, Eagle Point Credit Company has a trailing twelve months EPS of $1.74.
PE Ratio
Eagle Point Credit Company has a trailing twelve months price to earnings ratio of 5.82. Meaning, the purchaser of the share is investing $5.82 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.54%.
3. Bank7 Corp. (BSVN)
24.6% sales growth and 17.99% return on equity
Bank7 Corp. operates as a bank holding company for Bank7 that provides banking and financial services to individual and corporate customers. It offers commercial deposit services, including commercial checking, money market, and other deposit accounts; and retail deposit services, such as certificates of deposit, money market accounts, checking accounts, negotiable order of withdrawal accounts, savings accounts, and automated teller machine access. The company also provides commercial real estate, hospitality, energy, and commercial and industrial lending services; consumer lending services to individuals for personal and household purposes comprising residential real estate loans and mortgage banking services, personal lines of credit, loans for the purchase of automobiles, and other installment loans. It operates through a network of full-service branches in Oklahoma, the Dallas/Fort Worth, Texas metropolitan area, and Kansas. The company was formerly known as Haines Financial Corp. Bank7 Corp. was founded in 1901 and is headquartered in Oklahoma City, Oklahoma.
Earnings Per Share
As for profitability, Bank7 Corp. has a trailing twelve months EPS of $3.05.
PE Ratio
Bank7 Corp. has a trailing twelve months price to earnings ratio of 9.2. Meaning, the purchaser of the share is investing $9.2 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.99%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Mar 20, 2024, the estimated forward annual dividend rate is 0.79 and the estimated forward annual dividend yield is 2.82%.
Volume
Today’s last reported volume for Bank7 Corp. is 6965 which is 51.46% below its average volume of 14350.
4. California Resources Corporation (CRC)
22.4% sales growth and 27.63% return on equity
California Resources Corporation operates as an independent oil and natural gas company committed to energy transition in the sector. It has carbon intensity production in the United States, as well as focuses on developing carbon capture and storage (CCS) and other emissions reducing projects. The company explores for, produces, gathers, processes, and markets crude oil, natural gas, and natural gas liquids for marketers, California refineries, and other purchasers that have access to transportation and storage facilities. It holds interests in approximately 2.1 million net mineral acres covering four oil and gas basins. As of December 31, 2020, the company had proved reserves of 442 million barrels of oil equivalent. It also engages in the generation and sale of electricity to the local utility, other third parties, and the grid. The company was incorporated in 2014 and is based in Santa Clarita, California.
Earnings Per Share
As for profitability, California Resources Corporation has a trailing twelve months EPS of $7.78.
PE Ratio
California Resources Corporation has a trailing twelve months price to earnings ratio of 6.94. Meaning, the purchaser of the share is investing $6.94 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.63%.
Yearly Top and Bottom Value
California Resources Corporation’s stock is valued at $53.98 at 11:22 EST, below its 52-week high of $58.44 and way above its 52-week low of $35.19.
Volume
Today’s last reported volume for California Resources Corporation is 5157970 which is 436.71% above its average volume of 961021.
Revenue Growth
Year-on-year quarterly revenue growth declined by 27.5%, now sitting on 2.77B for the twelve trailing months.
Moving Average
California Resources Corporation’s worth is above its 50-day moving average of $51.72 and above its 200-day moving average of $51.45.
5. Eli Lilly and Company (LLY)
19.2% sales growth and 48.44% return on equity
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Earnings Per Share
As for profitability, Eli Lilly and Company has a trailing twelve months EPS of $5.78.
PE Ratio
Eli Lilly and Company has a trailing twelve months price to earnings ratio of 130.48. Meaning, the purchaser of the share is investing $130.48 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 48.44%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Feb 14, 2024, the estimated forward annual dividend rate is 5.2 and the estimated forward annual dividend yield is 0.68%.
Yearly Top and Bottom Value
Eli Lilly and Company’s stock is valued at $754.17 at 11:22 EST, under its 52-week high of $800.78 and way higher than its 52-week low of $317.24.
Moving Average
Eli Lilly and Company’s value is above its 50-day moving average of $688.83 and way higher than its 200-day moving average of $569.79.
6. ExlService Holdings (EXLS)
8.9% sales growth and 22.4% return on equity
ExlService Holdings, Inc. operates as a data analytics, and digital operations and solutions company in the United States and internationally. It operates through Insurance, Healthcare, Analytics, and Emerging Business segments. The company provides digital operations and solutions and analytics-driven services across the insurance industry in areas, such as claims processing, premium and benefit administration, agency management, account reconciliation, policy research, underwriting support, new business acquisition, policy servicing, premium audit, surveys, billing and collection, commercial and residential survey, and customer service using digital technology, artificial intelligence, machine learning, and advanced automation; digital customer acquisition services using a software-as-a-service delivery model through LifePRO and LISS platforms; subrogation services; and Subrosource software platform, an end-to-end subrogation platform. It also offers CareRadius, an integrated care management offering; and health care services related to care management, utilization management, disease management, payment integrity, revenue optimization and customer engagement to healthcare payers, providers, pharmacy benefit managers, and life sciences organizations. Further, it offers predictive and prescriptive analytics in the areas of customer acquisition and lifecycle management, risk underwriting and pricing, operational effectiveness, credit and operational risk monitoring and governance, payment integrity and care management, and data management. The company was founded in 1999 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, ExlService Holdings has a trailing twelve months EPS of $1.1.
PE Ratio
ExlService Holdings has a trailing twelve months price to earnings ratio of 28.28. Meaning, the purchaser of the share is investing $28.28 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.4%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
ExlService Holdings’s EBITDA is 3.22.
7. Verra Mobility Corporation (VRRM)
7% sales growth and 17.48% return on equity
Verra Mobility Corporation provides smart mobility technology solutions and services in the United States, Canada, and Europe. It operates through two segments, Government Solutions and Commercial Services. The Government Solutions segment offers automated safety solutions, including services and technologies that enable photo enforcement through road safety camera programs, which detects and process traffic violations related to red light, speed, school bus, and city bus lanes. This segment serves municipalities, counties, school districts, and law enforcement agencies. The Commercial Services segment provides automated toll and violations management, and title and registration solutions to rental car companies, fleet management companies, and other large fleet owners. The company is headquartered in Mesa, Arizona.
Earnings Per Share
As for profitability, Verra Mobility Corporation has a trailing twelve months EPS of $0.36.
PE Ratio
Verra Mobility Corporation has a trailing twelve months price to earnings ratio of 65.5. Meaning, the purchaser of the share is investing $65.5 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.48%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Verra Mobility Corporation’s EBITDA is 5.89.
Volume
Today’s last reported volume for Verra Mobility Corporation is 2219370 which is 106.67% above its average volume of 1073870.
